Single Ascending Dose (SAD) Cohorts GS-9620

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

HBVHepatitis B

Phase 1

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

CompletedNCT01590654

Gilead SciencesHepatitis B

Start: 2012-04-30End: 2013-12-31Updated: 2013-12-20

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

CompletedNCT01590641

Gilead SciencesHBV, Hepatitis B

Start: 2012-04-30End: 2013-10-31Updated: 2013-11-14